This study prospectively analysed the relationships between observed to vary according to the type and number of lymphimmunophenotypic and cytogenetic features of blast cells in oid lineage antigens expressed. 9 The expression of some of 432 acute non-lymphoblastic leukemias (ANLL) at presentation.
Patients chromosome abnormalities
The study was initiated in March 1992 by the Groupe d'Etude Immunologique des Leucémies (GEIL), a French multicentric Introduction group that collects data from over 40 centers in France and Belgium. The endpoint of the present analysis was 30 SepIn 1988 , the morphologic, immunologic and cytogenetic tember 1994. Patients eligible for the study met the following working classification (MIC) of acute non-lymphoblastic leucriteria: established diagnosis of ANLL and collection of a sufkemia (ANLL) 1 underlined the correlations between some ficient number of blast cells for both immunophenotype and recurrent specific cytogenetic abnormalities and defined cytosuccessful cytogenetic analysis. M0-ANLL were defined as logic subgroups. At that time, the relationships between cytopreviously reported. 2 FAB data were collected from each genetic features identified in ANLL and the immunophenotype center's cytology laboratory. of blast cells remained poorly characterised. During the last 10 years, immunophenotypic analysis of ANLL blast cells has provided new information and become a powerful tool in Immunological phenotyping assigning undifferentiated acute leukaemia to the myeloid lineage. 2 Meanwhile, investigation of lymphoid lineage antigens Mononuclear cells were recovered from heparinized bone on blast cells from a large number of ANLL has demonstrated marrow (391 cases) or peripheral blood (41 cases) collected the high immunophenotypic heterogeneity of morphologically at diagnosis. The percentage of blast cells after separation on and cytogenetically well-defined diseases. [3] [4] [5] [6] [7] [8] a Ficoll gradient was higher than 50% in M2 and M4 subtypes Molecular analyses attempting to correlate these immunoand higher than 80% in the remaining cases. The immunophenotypic features to their genotypic counterpart did not phenotype was performed by flow cytometry on blast cells demonstrate any strict correlation between the rearrangement gated on their abnormal light scatter characteristics, using of immunoglobulin and T cell receptor genes and the monoclonal antibodies for the following antigens: CD9 expression of lymphoid lineage antigens on ANLL blast (IOB2), CD11b (FD11), CD13 (MY7), CD14 (UCHM1), cells.
3, [9] [10] [11] However, the prevalence of genotypic changes was CD15a (SMY15a), CD16 (Leu11b), CD18 (IOT18), CD33 (MY9), CD34 (BI-3C5), CD35 (44-D), CD36 (OKM5), CDw65 (VIM2), CD41 (P2), CD42 (SZ2), T lymphoid differentiation 35 CD20 (B1) and CD24 (IOB3). In addition, cells were labelled the least significant factor and repeating the analysis until only markers with significant values (P Ͻ 0.05) were retained. with antibodies to TdT, glycophorin A and HLA-DR. All monoclonal antibodies were tested in indirect immunofluorescence on unpermeabilized or permeabilized cells (TdT).
Negative controls with isotype-matched non-relevant MoAb
Results allowed detection of non-specific binding. Peak shifting was considered to estimate the population of labelled blasts. A Descriptive analysis membrane marker was considered as positive when more than 20% of the blast cells expressed it. This value was selecThe percentage of positive samples for a given monoclonal antibody varied from 3% (CD42) to 73% (CD18) (data not ted by reference to previous published immunophenotyping AML studies 3, 4, 8, 10, 17, 18 and to the recent proposals of the EGIL shown). Seven markers were expressed in more than 50% of ANLL cases, namely CD18 (73%), CD13 (72%), CD33 (68%), group. 19 The cut-off was also 20% for TdT. Two internal workshops performed in 1988 and 1991 established the inter-HLA-DR (65%), CD15 (63%), CDw65 (58%) and CD34 (54%). All the ANLL studied expressed at least one of the panlaboratory reproducibility of the GEIL. The concordance of immunophenotypes performed on five different coded myeloid surface antigens CD13, CD33 or CDw65. In 115 of the 402 tested cases (29%) at least one B lineage marker samples distributed to all laboratories reached 94%.
(CD10, CD19, CD20, CD24) was detected. One hundred and thirty-four of the 421 patients tested (32%) expressed at least one T lineage marker. TdT and CD9 were detected in 16 and Cytogenetic methods 47% of the cases tested, respectively. Two hundred and thirty-two patients (54%) had chromoStandard cytogenetic techniques were used. In all cases, R-or G-banding was performed after culture of bone marrow cells some abnormalities (Tables 1 and 2 ) including structural aberrations in 183 patients (79%) and numerical changes in 128 or peripheral blood cells for 1, 24 or 48 h. The karyotypes were designated according to the International System for cases (55%) or both in 79 cases (34%). The karyotype was considered as complex in 66 cases (28%). Hematological Human Cytogenetics Nomenclature. 20 An abnormal clone was defined as two or more metaphase parameters were similar in ANLL with and without abnormal karyotype. cells with identical structural abnormalities or identical extra chromosomes, or three or more metaphases with missing An abnormal karyotype was more frequently seen in M0-ANLL and promyelocytic acute leukemias compared to other chromosomes. For the case to be considered cytogenetically normal, ie normal diploid, at least 15 metaphase cells had to FAB subgroups (respectively 77 and 83% of M0-and M3-ANLL subtypes). The 22 cases with t(15;17) were all seen be examined and all had to be normal.
Patients were divided into three main cytogenetic categoramong the 30 M3-ANLL. Similarly, the 21 t(8;21) were all within the group of 109 M2-ANLL, and were associated with ies: (1) normal diploid karyotype. (2) Structural abnormalities classified as t(8;21), t(15;17), inv(16), 3q21-q26 rearrangea missing sex chromosome in seven cases. The 15 cases of pericentric inversion of chromosome 16 were also all detected ment, 11q23 rearrangement, t(9;22), del(5q), del(7q), other simple structural abnormalities, and complex structural abnoramong the 17 M4-ANLL with bone marrow eosinophily (M4Eo); del(16)(q22) was seen in two other ANLL cases of malities (more than three structural changes). A given structural chromosome change was considered present regardless respectively M1 and M2 FAB subtypes. Most of the M5-ANLL had a normal karyotype. of the fact that it was the sole aberration or associated with numerical abnormalities. (3) Numerical abnormalities were Most of the chromosome 5 and chromosome 7 aberrations were observed in M1 or M2 FAB subtypes ANLL (76 and 66%, classified as trisomy 8 (alone or associated with a maximum of two other numerical changes), other hyperdiploidy, loss of respectively). Rearrangements of the 11q23 region, including del(11)(q23), t(9;11)(p21;q23), t(11;19)(q23;p11), t(11;15) a sexual chromosome, loss of chromosome 5, loss of chromosome 7, and other hypodiploidy. Each subset of numerical (q23;q12) and others were mainly observed in M4-and M5-ANLL (65%). abnormality category was analysed as present or absent, whether or not structural aberrations were associated.
Among patients with a history of myeloproliferative disorder (MPD), 15 had chronic myelogenous leukemia (CGL). Phi Each case of ANLL with an abnormal karyotype at presentation was analysed by the presence of either structural or chromosome and additional changes were seen in 10 of 14 patients with blast crisis of CGL (71%), leading to a complex numerical changes or both. Thus the relationships between immunophenotypic data and each structural numerical cytokaryotype in six cases (43% Detection of immunophenotypes associated with cytogenetic anomalies test was used to evaluate the differences between groups for continuous variables. A logistic regression analysis was performed to determine the markers with the best significant value The predictive value of differentiation antigen expression as indicators of chromosomal abnormalities was tested both in to predict abnormal karyotype at diagnosis, using univariate and multivariate analysis. All markers of significant value in univariate and multivariate analysis. Using univariate analysis, the expression of five differenunivariate analysis were first entered in the multivariate analysis. Then, a step-down procedure was adopted by removing tiation antigens appeared significantly associated with the presence of at least one cytogenetic abnormality. They were karyotype (P = 0.04). TdT expression was frequently related to complex cytogenetic aberrations: nine patients (23%) had a CD9 (P Ͻ 0.02), CD10 (P Ͻ 0.04), CD15 (P = 0.04), CD34 (P Ͻ 0.001) and TdT (P = 0.038) ( Table 3 ). The expression of complex karyotype and in a subgroup of TdT-positive ANLL (n = 5), which expressed simultaneously CD34 and CD10, all each of these antigens was statistically related to the presence of either a structural or a numerical cytogenetic abnormality.
cases had complex karyotypes. Furthermore, 30% of ANLL with a complex karyotype were found to express TdT. The relative risk of identifying a complex karyotype in CD10 + , TdT + and CD34 + ANLL was significantly increased to 3.0, 2.0 Multiparameter analysis with logistic regression was then used to study the relationships between the expression of each and 1.5 respectively, when compared to their negative counterpart.
of the five markers found to have a significant value in univariate analysis and the presence of a cytogenetic abnormality. An abnormal karyotype was identified in 91 of 153 CD9 + ANLL (59%), without relationship to any specific recurrent
The best model with a good predictive value for the presence of an abnormal karyotype at diagnosis was obtained when cytogenetic abnormality. Combination of CD9 expression with other antigens expression indicated a higher proportion CD34 (P Ͻ 0.00005) and CD9 (P Ͻ 0.03) were entered in the model (logistic regression: P = 0.00001 Table 3) . A structural aberration was detected in 17 cases (89%) either (89%); P = 0.006). The six M2-ANLL combining t(8;21) and a missing sex chromosome expressed no lymphoid lineage antialone (seven cases) or in association with a numeric aberration (10 cases).
gen. Thirty-seven percent of the 15 t(8;21) ANLL cases without a missing sex chromosome exhibited CD19 expression while CD15 expression, investigated in 336 cases, was associated with an abnormal karyotype in 119 cases (P = 0.04), and more lymphoid lineage antigens were detected rarely in other M2-ALL. specifically with structural anomalies (P = 0.05).
CD34 expression was observed in 42% of ANLL cases with a normal karyotype but 64% of the cases with karyotypic anomalies, and correlated strongly with the presence of clonal M3 -t(15;17): Overall, the expression of differentiation antigens was lower in ANLL with t(15;17) compared to other cytogenetic abnormalities (P = 0.0002). CD34 was expressed in more than 80% of ANLL with either 3q21q26 rearrangecytogenetic subgroups, including ANLL with a normal karyotype. ANLL with t(15;17) expressed mainly CD13 and CD15 ment, t(8;21), inv(16), −5/5q−, −7/7q−, or hyperdiploidy with more than 50 chromosomes. Conversely ANLL blast cells with whereas HLA-DR, CD34 and lymphoid lineage antigens were rarely detected in this subgroup. Eighty-one percent of M3-t(15;17) were stained by CD34 in only four of 20 cases (20%). , and P = 10 lineage markers: −5/5q− ANLL expressed CD14 in more than half of the cases, whereas this antigen was expressed infrequently in −7/7q− ANLL, and was not detected in the 11 ANLL with 3q21−q26 rearranged bands. CDw65 was M1:
The expression of CD34 in M1-ANLL was clearly related to the presence of an abnormal karyotype at diagnosis.
expressed mainly in ANLL with 3q21−q26 rearrangement. Lymphoid lineage markers were expressed infrequently in Thirty-two of 46 (70%) M1-ANLL with an abnormal karyotype expressed CD34 compared to 20 of 50 (40%) M1-ANLL with-−5/5q ANLL, with no detectable expression of CD5, CD10, CD20 and CD24. Conversely, −7/7q− ANLL blast cells were out cytogenetic abnormality (P Ͻ 0.005).
stained by CD2 in six of 29 cases (26%), and by at least one of the three T lineage markers studied in nine of the 25 tested cases (36%). At least one B lineage antigen was also detected M2:
Of the 63 M2 cases with karyotypic anomalies, 21 were the t(8;21) discussed above. In the other cases, seven in eight of the 21 tested cases (38%). Overall, at least one lymphoid lineage antigen was expressed in 13 of the 26 trisomy 8, 10 chromosome 5 (n = 5) or 7 (n = 5) aberrations were observed. The remaining cases had miscellaneous −7/7q− ANLL (50%) in which at least four lymphoid lineage antigens were studied. anomalies including six complex karyotypes.
M3:
Twenty-five of the 30 M3 cases had chromosomal Trisomy 8: ANLL with trisomy 8 expressed mainly CD13 and CD33. This ANLL subset differed from other ANLL with anomalies, with 22 t(15;17) described above. No specific immunophenotype appeared associated with the other three abnormal karyotypes by the lower frequency of CD34 expression (11 of 26 (42%) compared to 123 of 184 (67%); cases, which displayed respectively a trisomy 8 in one case and an hyperdiploidy in two. P Ͻ 0.02). CD34 antigen expression in this subgroup of ANLL was not different from that in ANLL with a normal karyotype and was similar in ANLL with trisomy 8 alone (n = 13) or associated with additional cytogenetic aberrations (n = 20 None of the CD16-expressing ANLL had a hypoploid expressed CD33, CD15 and either a B or T lymphoid lineage marker. karyotype.
The most prominent relationships observed between expression patterns of differentiation antigens and specific karyotypes are summarised in Table 6.  11q23 rearrangements: ANLL with a rearranged 11q23 band expressed mainly CD15, CD18 and HLA-DR and exhibited at least one B lineage antigen in 35% of the cases. However, this subgroup of 11q23 rearranged ANLL appeared to be Discussion immunologically heterogeneous (Table 5 ). The nine cases with del (11)(q23) were characterised by the frequent
The present study analysed the relationships between cytologic, immunophenotypic and cytogenetic features in 432 expression of CD15 (77%), CD33 (77%) and CD34 (67%), and displayed at least one B lineage marker in most cases ANLL at diagnosis. Although it demonstrated that the expression of several differentiation antigens on ANLL blast (63%). Conversely, the five ANLL with t(9;11) all expressed CD15 but lacked CD14, CD34 and lymphoid lineage markers. cells could be significantly predictive of karyotypic anomalies, this work mostly indicates the absence of specific immunoLastly, ANLL with other 11q23 rearrangements (n = 6) all phenotypes associated with given chromosomal aberrations. turbed regulatory control of this glycoprotein rather than CD34 gene involvement in the leukemic process. More precisely, homogeneous immunophenotypic subgroups could probably be defined, including cases with similar
The expression of CD9 previously reported in 30-50% ANLL 8, 21, 22 was also related to the presence of cytogenetic abnormal karyotypes and cases with normal cytogenetic features. We, however, attempted to identify the most frequent abnormalities although no specific relationship with a given abnormality was observed. CD9 positivity was not related to immunophenotypic features associated with classical karyotypic anomalies, both within and outside FAB subgroups.
classical prognostic factors including white blood cell count, extra-medullary disease, or previous history of myelodysplasia The series analysed, collected in a multicentric fashion, is comparable to most previously reported series of ANLL. FAB or myeloproliferative disease. If no precise function has been assigned to the CD9 molecule which belongs to the tetraspan subtypes were mainly M1/M2 (50%) and M4/M5 (35%). In all cases, blast cells expressed at least one of the pan-myeloid superfamily, there are some indications that it could be involved in cell adhesion and migration. 25 In ALL it has been markers. The expression of the 24 differentiation antigens studied was consistent with previously reported studies. 8, 21, 22 shown that CD9 is released by CD9-positive ALL blast and may be related to poor prognosis. 26 Interestingly, the combiAt least one cytogenetic abnormality was identified in 54% of cases.
nation of CD9 expression and the absence of CD18 expression or the simultaneous expression of CD34 or CD10 We first analysed the relationships between the expression of a given antigen on blast cells and the cytogenetic features identified subgroups of ANLL with a high incidence of cytogenetic abnormalities. of these cells, in order to detect possibly predictive immunophenotypic features, using univariate analysis. Five differenImmunophenotypic characteristics of karyotypic anomalies associated with precise FAB subtypes were also analysed. This tiation antigens appeared significantly associated with karyotypic anomalies. They were CD9, CD10, CD15, CD34 and demonstrated a less frequent expression of CD13 in t(8;21) M2-ANLL associated with the frequent expression of CD15, TdT, associated with cytogenetic anomalies in 59, 76, 57, 64 and 67% of positive cases, respectively. In multivariate analy-CD18 and CD34, and CD19 expression in such cases without anomalies of sex chromsomes. M3-ANLL with t(15;17) often sis, the expression of CD34 appeared as the major immunophenotypic feature related to the presence of clonal cytohad an otherwise unusual CD13
− immunophenotype, frequently associated with CD15 expression, congenetic abnormalities, while CD9 expression was predictive of any given type of karyotypic anomaly. sistent with previous reports describing the lack of DR expression in M3-ANLL. 8, 27 In M4 cases, inv(16) was strongly Using the My10 MoAb, CD34 expression has previously been shown to be related to 16q22 rearrangement, t(8;21), associated with CD34 and CD13 expression, often associated with CD36. −5/5q− or −7/7q− abnormalities.
6, [16] [17] [18] 23 Here, we showed that del(11)(q23) and 3q21-q26 rearrangements, which are Independently of FAB subtyping, t(9;22) appeared significantly associated with B lineage markers, as demonstrated often associated with monosomy 7, are also related to CD34 expression. Conversely, neither trisomy 8 nor rearranged previously. 5,7,28,29 A t(9;22)(q34;q11) was identified in nine out of 380 de novo ANLL. When compared to acute CGL, 11q23 band other than del(11)(q23) were related to CD34 overexpression when compared to ANLL with a normal karyothese de novo Phi-positive ANLL expressed significantly less CD11b whereas the expression of the ␤2 integrin CD18, was type. As most M0-ANLL expressed CD34, its expression was found to be independent of the cytogenetic status in this subsimilar in both groups. In normal myelopoiesis, CD11b has been reported to be associated with commitment to terminal group where it could be related to the immaturity of the leukemic progenitor cell. Conversely, in M1/M2-and M4/M5-granulocytic differentiation. 30 Whether CD11b expression in acute CGL reflects a more differentiated phenotype remains ANLL, the expression of CD34 was related to the presence of cytogenetic abnormalities. It may also be noted that several to be determined. Blasts from the 4.5% of patients with 11q23 anomalies were groups have reported CD34 expression to be of pejorative prognosis in ANLL. 8, 17 High CD34 antigenic density was also often CD15 + . The incidence of 11q23 anomalies in our series is in accordance with previous reports. [31] [32] [33] [34] [35] This cytogenetic recently reported in combination with CD15 and cytoplasmic myeloperoxidase in numerous ANLL subsets 24 including M2-abnormality was also described in B lineage ALL, exhibiting in some cases myeloid features at diagnosis with expression ANLL with t(8;21). 16 Such an asynchronous expression of CD34 with myeloid differentiation antigens suggests a disby blast cells of CD15 or CDw65 antigens or relapsing with a myeloid phenotype. 28, [36] [37] [38] In the present series of ANLL, we malies. However, it clearly appears from this study that prognostic features independent from karyotypic anomalies should found evidence of B lineage lymphoid antigen expression in half of 11q23 rearranged cases without t(9;11) or t (11;19) . be investigated in specific immunophenotypic subgroups. The expression of CD16 in about 15% ANLL cases was consistent with previous reports 8, 24, 39 and strongly related to hyperdiploid karyotypes. This unique direct relationship between Acknowledgements the expression of a single antigen and a given cytogenetic abnormality has to be explored further. The type of CD16
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